FDA Inspection 752749 — Gulf Pharmaceutical Industries - Julphar
The FDA completed an inspection of Gulf Pharmaceutical Industries - Julphar on October 3, 2011 in Ras Al Khaimah. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- October 3, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ras Al Khaimah (United Arab Emirates)